PlainRecalls
FDA Drug Low Class III Terminated

Matzim LA (Diltiazem Hydrochloride) Extended-Release Tablets, 240 mg, 30 count bottle, Rx only, Manufactured by: Actabis Laboratories FL, Inc., Fort Lauderdale, FL, Distributed by: Actavis Pharma, Inc., Parsippany, NJ NDC 52544-692-30

Reported: October 16, 2019 Initiated: September 6, 2019 #D-0131-2020

Product Description

Matzim LA (Diltiazem Hydrochloride) Extended-Release Tablets, 240 mg, 30 count bottle, Rx only, Manufactured by: Actabis Laboratories FL, Inc., Fort Lauderdale, FL, Distributed by: Actavis Pharma, Inc., Parsippany, NJ NDC 52544-692-30

Reason for Recall

GMP Deviation: lot not intended for commercial distribution.

Details

Recalling Firm
Teva Pharmaceuticals USA
Units Affected
5,849 bottles
Distribution
Product was distributed to 42 wholesalers and 11 retailers who may have further distribute the product throughout the United States, including Hawaii and Puerto Rico.
Location
Parsippany, NJ

Frequently Asked Questions

What product was recalled?
Matzim LA (Diltiazem Hydrochloride) Extended-Release Tablets, 240 mg, 30 count bottle, Rx only, Manufactured by: Actabis Laboratories FL, Inc., Fort Lauderdale, FL, Distributed by: Actavis Pharma, Inc., Parsippany, NJ NDC 52544-692-30. Recalled by Teva Pharmaceuticals USA. Units affected: 5,849 bottles.
Why was this product recalled?
GMP Deviation: lot not intended for commercial distribution.
Which agency issued this recall?
This recall was issued by the FDA Drug on October 16, 2019. Severity: Low. Recall number: D-0131-2020.